Back
Pharma Facade Crumbles: Punjab HC Rejects Bail in Massive 5,700 Kg Psychotropic Bust
In a stark reminder that legal licenses don't license crime, the has dismissed regular bail pleas from eight accused linked to a staggering seizure of over 1.37 crore psychotropic tablets weighing 5,772 kg. Justice Sumeet Goel ruled that the strict barriers of stand firm, rejecting claims that licensed pharmaceutical operations could whitewash allegations of organized diversion into black markets.
The judgment covers petitions like Aashish Verma v. Union of India (CRM-M-46779-2025) and seven connected matters, all stemming from NCB Crime Case No. 51/2024 at .
From Secret Tip to Seizure Empire
It began with a secret tip to the Amritsar on , unraveling a web of illicit trade in Alprazolam, Tramadol, and Zolpidem Tartrate—psychotropic substances fueling addiction crises. Raids snowballed: 35,120 Alprazolam and 1,220 Tramadol tablets from Sukhpal Singh and Harvinder Singh; more from Sonu Singh, Heera Singh (Diljit), and others. Follow-ups hit "shell" firms like IKON Pharmachem (Dehradun), Embit Bio Medix (Poanta Sahib), and Life Care Pharma (Kolkata), exposing layers of fake addresses, canceled licenses, and airport detentions—like Kaushik's foiled Vietnam escape.
Challan filed, 50 witnesses listed, zero examined. Petitioners, in custody 8-14 months by decision time, sought release under , arguing trial delays and clean ledgers.
Defenses of Legitimacy vs. Confessions of Guilt
Petitioners painted themselves as upstanding pharma players. Aashish Verma, IKON director, stressed valid
licenses (Schedules C, C(1), X), sales only to "authorized" Embit Bio Medix. Kaushik (Embit proprietor) and Arjun Singh (Life Care Pharma) echoed: no direct sales to crooks, no personal recovery, just disclosure-based links. Others like Manpreet Singh, Naveen Gupta (Welfare Medicos), Sonu, Sukhpal, and Harsh Kumar claimed false implication via co-accused statements, cooperation with probes, and prior NDPS nods denied.
"Rigors of S.37 NDPS not attracted,"
they chorused, citing finished probes and incarceration pangs.
NCB fired back with a confessional cascade under . Aashish admitted selling 1 crore "Nox" tablets to dubious Embit despite knowing its black-market flip. Kaushik confessed relaunching Embit post-license cancellation via proxies like Aashi Pharma, hoarding millions of tablets. Arjun divulged 1.7 crore Tramadol tabs to ghost firms (RV Pharma, etc.). Naveen funded "dummy" stores with murky crores; linkages via WhatsApp calls (96 between Manpreet-Heera), prior FIRs, and seizures from marketed batches sealed the chain. "Commercial quantity, planned racket," NCB urged, warning of flight risks and repeat threats.
Sifting Substance Over Form: NDPS Rigors Unyielding
Justice Goel navigated Section 37's twin hurdles—reasonable belief of guilt and no reoffend risk—without . Citing Supreme Court in Union of India v. Namdeo Ashruba Nakade (SLP CrL 9792/2025), he underscored India's youth-drug scourge: 316 million global users, generational ruin. Union of India v. Vigin K. Varghese (SLP CrL 7768/2025) demanded scrutiny of control, . Locally, Jaswinder Singh v. State of Punjab (2025:P&H) outlined bail postulates: sift material , matter, but no auto-denial.
No blind faith in licenses here.
"Legality of form cannot defeat scrutiny of substance,"
the bench held, noting shell firms, diversions to non-operational addresses, and profit-driven confessions. Bail discretion narrows for
"organised diversion under guise of lawful ops,"
echoing
. Trial underway, no undue delay blame on accused—petitions fell.
Key Observations
"The grant of bail, though discretionary, assumes a narrower compass where allegations pertain to organised diversion of regulated pharmaceutical substances into illicit channels under the guise of lawful business operations."
"Courts have consistently cautioned that entities operating within the pharmaceutical sector cannot be permitted to cloak unlawful activities behind the facade of licences or corporate structures..."
"Commercial sophistication cannot be permitted to become a shield against criminal accountability."
", the petitioner(s) are accused of having dealings in narcotic substances with the firm(s) which exist only on papers and not physically."
Bail Blue Line: Trial Must March On
Petitions dismissed outright. No merits opinion expressed, miscellaneous apps closed. Practical fallout? Pharma probes intensify; Section 37 bites harder against "sophisticated" traffickers. As other reports note, licenses canceled (Embit, Aashi), this signals zero tolerance for NRx rackets ravaging Punjab's youth—echoing national alarms on SUD crises.
Future cases: Expect courts to routinely in NDPS chains, prioritizing societal shield over personal liberty claims amid delays.
